Antiretroviral Therapy Update 2016

In this downloadable slideset, Joseph J. Eron, Jr., MD, reviews the evidence behind the latest antiretroviral guidelines and offers a glimpse at potential future agents and strategies currently under investigation.
Format: Microsoft PowerPoint (.ppt)
File Size: 2.05 MB
Released: June 1, 2016


Jointly provided by the Annenberg Center for Health Sciences at Eisenhower and Clinical Care Options, LLC

Contact Clinical Care Options

For customer support please email:

Clinical Care Options, LLC
12001 Sunrise Valley Drive
Suite 300
Reston, VA 20191

Educational grant provided by:
Bristol-Myers Squibb
Gilead Sciences
Janssen Therapeutics
Merck & Co., Inc.
ViiV Healthcare

Related Content

Expert commentary by Dr Jürgen K. Rockstroh on screening for and identifying NASH in the setting of HIV, from Clinical Care Options (CCO)

Jürgen K. Rockstroh, MD Released: January 7, 2022

From Clinical Care Options (CCO) and Dr. Jurgen K. Rockstroh and Dr. Giada Sebastiani: the risk factors of NAFLD or NASH in patients with HIV

Jürgen K. Rockstroh, MD Giada Sebastiani, MD Physicians: maximum of 0.25 AMA PRA Category 1 Credits Released: December 7, 2021 Expired: December 6, 2022

Clinical Care Options (CCO) expert commentary by Giada Sebastiani, MD, on the importance of looking for NAFLD/ NASH in patients with HIV

Giada Sebastiani, MD Released: September 29, 2021

Downloadable PDF resource from CCO on HCV and HIV screening essentials and HIV PrEP basics for addiction medicine specialists

Andrew Seaman, MD Released: October 2, 2020

Leaving the CCO site

You are now leaving the CCO site. The new destination site may have different terms of use and privacy policy.


Cookie Settings